ID: ALA3134405

Max Phase: Preclinical

Molecular Formula: C13H8ClN3O5

Molecular Weight: 321.68

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1cccc([N+](=O)[O-])c1)c1ccc([N+](=O)[O-])cc1Cl

Standard InChI:  InChI=1S/C13H8ClN3O5/c14-12-7-10(17(21)22)4-5-11(12)13(18)15-8-2-1-3-9(6-8)16(19)20/h1-7H,(H,15,18)

Standard InChI Key:  JJQYADUMZGPKJC-UHFFFAOYSA-N

Associated Targets(Human)

DNA topoisomerase II alpha 6317 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Escherichia coli 133304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bacillus subtilis 32866 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DNA topoisomerase 69 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 321.68Molecular Weight (Monoisotopic): 321.0152AlogP: 3.41#Rotatable Bonds: 4
Polar Surface Area: 115.38Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.50CX Basic pKa: CX LogP: 3.55CX LogD: 3.55
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.68Np Likeness Score: -1.92

References

1. Lin H, Annamalai T, Bansod P, Tse-Dinh YC, Sun D..  (2013)  Synthesis and antibacterial evaluation of anziaic acid and analogues as topoisomerase I inhibitors.,  (12): [PMID:24363888] [10.1039/c3md00238a]

Source